Your browser doesn't support javascript.
loading
MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing.
Westley, Rosalyne L; Valle, Luca F; Tree, Alison C; Kishan, Amar U.
Afiliación
  • Westley RL; The Royal Marsden Hospital, Sutton, England, UK; The Institute of Cancer Research, Sutton, England, UK. Electronic address: Rosalyne.westley@rmh.nhs.uk.
  • Valle LF; Department of Radiation Oncology, University of California, Los Angeles, CA, USA. Electronic address: lfvalle@mednet.ucla.edu.
  • Tree AC; The Royal Marsden Hospital, Sutton, England, UK; The Institute of Cancer Research, Sutton, England, UK.
  • Kishan AU; Department of Radiation Oncology, University of California, Los Angeles, CA, USA.
Semin Radiat Oncol ; 34(1): 45-55, 2024 01.
Article en En | MEDLINE | ID: mdl-38105093
ABSTRACT
The advent of MRI guided radiotherapy (MRIgRT) offers enormous promise in the treatment of prostate cancer. The MR-linac offers men the opportunity to receive daily MR imaging to guide and influence their radiotherapy treatment. This review focuses on the advantages that MRIgRT potentially offers as well as any potential disadvantages to MRIgRT that may have been recognized thus far. Ongoing clinical trials evaluating this novel treatment platform for the treatment of prostate cancer are also discussed.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioterapia Guiada por Imagen Límite: Humans / Male Idioma: En Revista: Semin Radiat Oncol Asunto de la revista: NEOPLASIAS / RADIOLOGIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioterapia Guiada por Imagen Límite: Humans / Male Idioma: En Revista: Semin Radiat Oncol Asunto de la revista: NEOPLASIAS / RADIOLOGIA Año: 2024 Tipo del documento: Article